Drug recall · May 14, 2025
Ropivacaine Hydrochloride Injection recall
Why: Presence of Particulate Matter
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)
- Lots / codes
Lot #'s: AL240003, AL240004, Exp.: 01/31/2026
- Quantity
- 62 (12x100mL) bags
- Company
- Amneal Pharmaceuticals, LLC, Bridgewater, NJ
- Distribution
- Nationwide in the US
- Initiated
- April 17, 2025 · Voluntary: Firm initiated
- Classified
- May 5, 2025
- Reported
- May 14, 2025
- Ended
- October 5, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ropivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.